Work

Reviewer #2 (Public review): Turning aging cells into a live vaccine: engineered senescent cancer cells with adjuvant celecoxib for immunotherapy

Year: 2026
Type: peer-review
Source: eLife
Language: English
Subfield: Immunology
Open Access status: gold
Estimated APC paid: $2,500
OpenAlex ID: W7225990511
Cites:
Cited by:
Related to: 10